BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18715553)

  • 1. Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma.
    Karyampudi L; Ghosh SK
    Cell Immunol; 2008; 254(1):74-80. PubMed ID: 18715553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of mycobacterial heat-shock protein 70 in DNA vaccination against lymphoma.
    Liso A; Benedetti R; Fagioli M; Mariano A; Falini B
    Haematologica; 2005 Jan; 90(1):60-5. PubMed ID: 15642670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine.
    Lim SY; Laxmanan S; Stuart G; Ghosh SK
    Cancer Detect Prev; 2001; 25(5):470-8. PubMed ID: 11718453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
    Spellerberg MB; Zhu D; Thompsett A; King CA; Hamblin TJ; Stevenson FK
    J Immunol; 1997 Aug; 159(4):1885-92. PubMed ID: 9257853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
    Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
    Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB; Sandlie I; Bogen B
    Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
    Benvenuti F; Burrone OR; Efremov DG
    Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Th1 immune response by CD8alpha(+) dendritic cells loaded with heat shock proteins enriched tumor extract in tumor-bearing mice.
    Azadmehr A; Pourfathollah AA; Amirghofran Z; Hassan ZM; Moazzeni SM
    Cell Immunol; 2009; 260(1):28-32. PubMed ID: 19712929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.
    Neeson P; Pan ZK; Paterson Y
    Cancer Immunol Immunother; 2008 Apr; 57(4):493-505. PubMed ID: 17876582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion proteins of Hsp70 with tumor-associated antigen acting as a potent tumor vaccine and the C-terminal peptide-binding domain of Hsp70 being essential in inducing antigen-independent anti-tumor response in vivo.
    Zhang H; Huang W
    Cell Stress Chaperones; 2006; 11(3):216-26. PubMed ID: 17009594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice.
    Hashemi SM; Hassan ZM; Soudi S; Ghazanfari T; Kheirandish M; Shahabi S
    Int Immunopharmacol; 2007 Jul; 7(7):920-7. PubMed ID: 17499194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
    Koide T; Iinuma H; Fukushima R
    Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma.
    Zhang H; Wang W; Li Q; Huang W
    Immunol Lett; 2006 Jun; 105(2):167-73. PubMed ID: 16580737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble PD-1 can augment anti-tumor immunity induced by HSP70-peptide complex in tumor-bearing mice].
    Wang XH; Zhang GM; He YF; Zhang H; Feng ZH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):655-8. PubMed ID: 15555427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and antitumor effects in mice.
    Carlring J; Szabo MJ; Dickinson R; De Leenheer E; Heath AW
    Blood; 2012 Mar; 119(9):2056-65. PubMed ID: 22234700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
    Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
    Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.